+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biogen Inc. - logo

Founded in 1978 Biogen Inc is a global biotechnology company with its headquarters in Cambridge, Massachusetts. In 2003 Biogen merged with Idec Pharmaceuticals to create Biogen Idec and acquired Syntonix Pharmaceuticals in 2007. In 2015 the company returned to its original name Biogen Inc and acquired Convergence Pharmaceuticals. Biogen focuses on drug discovery for a range of conditions including neuropathic pain, hemophilia, organ failure, neuromuscular disorders and oncology. Their product portfolio includes Rituxan, Avonex, Tecfidera and Eloctate.

Transforming Growth Factor Beta Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Transforming Growth Factor Beta Inhibitors - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 150 Pages
  • Global
From
Global Auto Injector Market Outlook 2030 - Product Thumbnail Image

Global Auto Injector Market Outlook 2030

  • Report
  • October 2021
  • 199 Pages
  • Global
From
From
From
Argentina Anti-Rheumatic Drug Market - Forecasts from 2022 to 2027 - Product Thumbnail Image

Argentina Anti-Rheumatic Drug Market - Forecasts from 2022 to 2027

  • Report
  • October 2022
  • 73 Pages
  • Argentina
From
Gastrointestinal Collaboration and Licensing Deals 2016-2025 - Product Thumbnail Image

Gastrointestinal Collaboration and Licensing Deals 2016-2025

  • Report
  • October 2025
  • 250 Pages
  • Global
From
Canada Anti-Rheumatic Drug Market - Forecasts from 2022 to 2027 - Product Thumbnail Image

Canada Anti-Rheumatic Drug Market - Forecasts from 2022 to 2027

  • Report
  • September 2022
  • 77 Pages
  • Canada
From
From
From
Loading Indicator